체외막산소화(ECMO) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global extracorporeal membrane oxygenation market size is expected to reach USD 752.67 Million in 2034 from USD 491.88 Million in 2025, growing at a CAGR of 4.84 during 2026-2034.This market is witnessing significant growth due to rising prevalence of severe respiratory and cardiac disorders worldwide. Extracorporeal membrane oxygenation systems provide life-support assistance for patients experiencing critical heart or lung failure. Increasing demand for advanced critical care solutions and growing use of ECMO during complex surgeries are strongly supporting market expansion. Technological advancements in oxygenation devices and monitoring systems are also improving treatment outcomes and patient survival rates globally.

Growing incidence of cardiovascular diseases, respiratory infections, and organ failure cases are major drivers influencing market growth. Hospitals and intensive care units are increasingly adopting ECMO systems for emergency and long-term critical care management. Rising healthcare expenditure and expansion of specialized critical care facilities are further boosting product adoption. In addition, increasing awareness regarding advanced life-support therapies and improved access to healthcare services are positively impacting the global market.

Future prospects for the ECMO market remain highly promising due to ongoing advancements in portable and compact life-support systems. Research activities focused on improving device safety, efficiency, and patient monitoring capabilities are expected to strengthen future growth. Emerging economies are likely to witness increased adoption because of expanding healthcare infrastructure and critical care investments. As demand for advanced respiratory and cardiac support technologies continues rising, the market is projected to experience sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Modality

• Venoarterial (VA)
• Veno-venous (VV)
• Arteriovenous (AV)

By Application

• Cardiac Diseases
• Respiratory Diseases
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Patient Population

• Infant
• Pediatric
• Adult

COMPANIES PROFILED

• Abbott Laboratories, Abiomed, Eurosets, Braile Biomedica, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Nipro, SB-Kawasumi Laboratories, Inc., Senko Medical Instrument Mfg. Co., Ltd., Spectrum Medical, Terumo Corporation, Weigao Group Co., Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY MODALITY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Modality
• 4.2. Venoarterial (VA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Veno-venous (VV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Arteriovenous (AV) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiac Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY PATIENT POPULATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Patient Population
• 6.2. Infant Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Modality
  • 7.2.2 By Application
  • 7.2.3 By Patient Population
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Modality
  • 7.3.2 By Application
  • 7.3.3 By Patient Population
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Modality
  • 7.4.2 By Application
  • 7.4.3 By Patient Population
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Modality
  • 7.5.2 By Application
  • 7.5.3 By Patient Population
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Modality
  • 7.6.2 By Application
  • 7.6.3 By Patient Population
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 Abiomed
  • 9.2.3 Eurosets
  • 9.2.4 Braile Biomedica
  • 9.2.5 Edwards Lifesciences Corporation
  • 9.2.6 Fresenius Medical Care AG & Co. KGaA
  • 9.2.7 Getinge AB
  • 9.2.8 Hemovent GmbH
  • 9.2.9 LivaNova PLC
  • 9.2.10 Medtronic
  • 9.2.11 MicroPort Scientific Corporation
  • 9.2.12 Nipro
  • 9.2.13 SB-Kawasumi LaboratoriesInc
  • 9.2.14 Senko Medical Instrument Mfg. Co.Ltd
  • 9.2.15 Spectrum Medical, Terumo Corporation
  • 9.2.16 Weigao Group Co.Ltd